Yifeng Pharmary(SH:603939) Shang Hai Zheng Quan Bao·2025-09-02 20:11Core Viewpoint - The company has approved the use of idle raised funds for wealth management, ensuring that it does not change the purpose of the funds or affect the normal operation of investment projects [2][4]. Group 1: Wealth Management Overview - The company plans to use a maximum of 300 million RMB for wealth management, focusing on low-risk financial products with high safety and liquidity [2]. - From April 21 to July 25, 2025, the company utilized 525 million RMB of idle raised funds to purchase structured bank deposits, remaining within the authorized limit [3]. - As of the announcement date, the total amount of raised funds used for wealth management that has not been redeemed is 219 million RMB [3]. Group 2: Risk Management - The company will adhere to prudent investment principles, selecting reputable issuers to ensure the safety of funds [4]. - An investment ledger will be established to track and analyze the status of each financial product, with timely measures taken to mitigate risks if adverse factors are identified [4]. - The audit department will conduct quarterly audits of the investment situation and report any issues to the audit committee [4][5]. Group 3: Fund Utilization and Return - The company has temporarily used up to 1.1 billion RMB of idle raised funds to supplement working capital for operations related to its main business, with a usage period not exceeding 12 months [10]. - The company has returned 10 million RMB to the raised funds account and will continue to repay the remaining balance in a timely manner [10].